Last reviewed · How we verify

NCT04651998

Effect of Carotid Artery Stent on Evoked Cerebral Blood Oxygenation and Neurocognitive Functioning

Status unknown Last updated 29 May 2024
What this trial tests

trial testing MMSE, MoCA, functional near-infrared spectroscopy in Carotid Artery Stenosis in 74 participants. Status unknown.

Timeline
1 May 2021
Primary endpoint
30 September 2024
30 December 2024

Quick facts

Lead sponsorShanghai Jiao Tong University Affiliated Sixth People's Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment74
Start date1 May 2021
Primary completion30 September 2024
Estimated completion30 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Who can join

Adults 35 to 80, any sex, with Carotid Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of vascular cognitive impairment that is amenable to treatment by revascularization. The effect of carotid artery stent on evoked cerebral blood oxygenation and neurocognitive functioning will be evaluated by functional near-infrared spectroscopy. Carotid artery stent could benefit cerebral blood oxygenation after stent and improving neurocognitive functioning after 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carotid Artery Stenosis

Currently open trials in the same condition.

Other Shanghai Jiao Tong University Affiliated Sixth People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04651998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing